Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control: A randomized controlled clinical trial.
Cardiometabolic health
Glycemic control
Insulin resistance
Magnesium
Osteocalcin
Vitamin D
Journal
Nutrition research (New York, N.Y.)
ISSN: 1879-0739
Titre abrégé: Nutr Res
Pays: United States
ID NLM: 8303331
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
24
05
2022
revised:
12
12
2022
accepted:
18
12
2022
pubmed:
15
1
2023
medline:
11
2
2023
entrez:
14
1
2023
Statut:
ppublish
Résumé
High-dose vitamin D supplementation can increase total osteocalcin concentrations that may reduce insulin resistance in individuals at risk for prediabetes or diabetes mellitus. Magnesium is a cofactor in vitamin D metabolism and activation. The purpose of this study was to determine the combined effect of vitamin D and magnesium supplementation on total osteocalcin concentrations, glycemic indices, and other bone turnover markers after a 12-week intervention in individuals who were overweight and obese, but otherwise healthy. We hypothesized that combined supplementation would improve serum total osteocalcin concentrations and glycemic indices more than vitamin D supplementation alone or a placebo. A total of 78 women and men completed this intervention in 3 groups: a vitamin D and magnesium group (1000 IU vitamin D
Identifiants
pubmed: 36640582
pii: S0271-5317(22)00145-2
doi: 10.1016/j.nutres.2022.12.005
pii:
doi:
Substances chimiques
Magnesium
I38ZP9992A
Osteocalcin
104982-03-8
Vitamin D
1406-16-2
Vitamins
0
Cholecalciferol
1C6V77QF41
Banques de données
ClinicalTrials.gov
['NCT03134417']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
33-43Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interests None.